IL-1 and TNF Antagonists Inhibit the Inflammatory Response and Bone Loss in Experimental Periodontitis

作者: S. Amar , D. Cochran , T. Oates , D. T. Graves , R. Assuma

DOI:

关键词:

摘要: Periodontal disease is the most frequent cause of tooth loss in humans and prevalent associated with bone loss, including osteoporosis. destruction initiated by bacteria that colonize surface, leading to inflammation resorption. To assess roles IL-1 TNF this process, studies were conducted a Macaca fascicularis primate model experimental periodontitis. Function-blocking soluble receptors applied local injection sites induced periodontal compared similar injected vehicle alone. The results indicate inhibited approximately 80% recruitment inflammatory cells close proximity bone. formation osteoclasts was reduced 67% at control sites, amount 60%. All statistically significant (p < 0.01). These findings component pathologic process periodontitis due IL-1/TNF activity, since inhibiting reduces both cell loss. data also suggest gingivitis actively protective, blocking further up-regulation host response inhibitors does not damage. Furthermore, these coupled recent evidence participate endocrine-associated osteoporosis multiple pathologies involving excessive may operate through common mechanism and/or TNF.

参考文章(37)
A C Windsor, C J Walsh, P G Mullen, D J Cook, B J Fisher, C R Blocher, S K Leeper-Woodford, H J Sugerman, A A Fowler, Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. Journal of Clinical Investigation. ,vol. 91, pp. 1459- 1468 ,(1993) , 10.1172/JCI116351
Max A. Listgarten, Pathogenesis of periodontitis. Journal of Clinical Periodontology. ,vol. 13, pp. 418- 425 ,(1986) , 10.1111/J.1600-051X.1986.TB01485.X
Philip Stashenko, John J. Jandinski, Philip Fujiyoshi, James Rynar, Sigmund S. Socransky, Tissue Levels of Bone Resorptive Cytokines in Periodontal Disease Journal of Periodontology. ,vol. 62, pp. 504- 509 ,(1991) , 10.1902/JOP.1991.62.8.504
Joachim Rothe, Werner Lesslauer, Hansruedi Lötscher, Yolande Lang, Pascale Koebel, Frank Köntgen, Alana Althage, Rolf Zinkernagel, Michael Steinmetz, Horst Bluethmann, Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes Nature. ,vol. 364, pp. 798- 802 ,(1993) , 10.1038/364798A0
Joachim Rothe, Gisela Gehr, Hansruedi Loetscher, Werner Lesslauer, Tumor necrosis factor receptors--structure and function. Immunologic Research. ,vol. 11, pp. 81- 90 ,(1992) , 10.1007/BF02918612
Roy C. Page, The role of inflammatory mediators in the pathogenesis of periodontal disease Journal of Periodontal Research. ,vol. 26, pp. 230- 242 ,(1991) , 10.1111/J.1600-0765.1991.TB01649.X
D. A. Russell, K. K. Tucker, N. Chinookoswong, R. C. Thompson, T. Kohno, Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: improved survival and organ function. The Journal of Infectious Diseases. ,vol. 171, pp. 1528- 1538 ,(1995) , 10.1093/INFDIS/171.6.1528
J. E. Sims, M. A. Gayle, J. L. Slack, M. R. Alderson, T. A. Bird, J. G. Giri, F. Colotta, F. Re, A. Mantovani, K. Shanebeck, Interleukin 1 signaling occurs exclusively via the type I receptor. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 6155- 6159 ,(1993) , 10.1073/PNAS.90.13.6155
Kevin J. Tracey, M.D, Anthony Cerami, Ph.D, Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annual Review of Medicine. ,vol. 45, pp. 491- 503 ,(1994) , 10.1146/ANNUREV.MED.45.1.491